# Thiazide and thiazide-like diuretics

Drug · id `cardio:thiazide-and-thiazide-like-diuretics` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Thiazide diuretics; Thiazide-like diuretics; Thiazides

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A group of diuretics used for high blood pressure and for swelling from fluid build-up. The US label read for hydrochlorothiazide, a thiazide, lists high blood pressure and fluid build-up from congestive heart failure. The label read for chlorthalidone, which the label says differs chemically from the thiazides, lists the same two uses, and the US drug record places it in a thiazide-like group.

## Technical summary

Class page for a group made of two sets. MeSH descriptor D049993 (Sodium Chloride Symporter Inhibitors, last updated 2021-06-30) is a broad match: it is named for the mechanism, agents that inhibit sodium chloride symporters and act as diuretics, and it holds a concept for thiazide diuretics (Diuretics, Thiazide). The chemical descriptor D049971 (Thiazides) is not used as the match, because MeSH defines it as heterocyclic compounds, commonly the benzothiadiazines, so it does not cover the thiazide-like members. Two US labels were read: hydrochlorothiazide tablets (application ANDA202556, effective 2026-04-01 in openFDA; established pharmacologic class Thiazide Diuretic) and chlorthalidone tablets (application ANDA211627, effective 2022-11-24 in openFDA; established pharmacologic class Thiazide-like Diuretic). Both are generic labels, not the original brand. The hydrochlorothiazide label says the mechanism of the antihypertensive effect of thiazides is unknown. The label texts read state no age range for their uses. This page gives no dose, no trial result and no guideline statement; the pregnancy and other warnings in the labels were not recorded. Medicines of the group that have their own pages are filed under it.

## Claims, with the population each applies to

## Context: People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic

Recipient: Recipient not specified; Population: Patients described in the indications sections of the two labels: patients with hypertension, and patients with edema associated with congestive heart failure (among other causes the labels list).; Care setting: Prescription medicine, as described in the US labels; Geography: United States (US drug labels); Life stage: Not stated in the passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### Two US generic labels were read. The label of hydrochlorothiazide tablets (Accord Healthcare Inc., application ANDA202556; the version dated 2026-04-01 in openFDA) calls the medicine a diuretic and antihypertensive and lists the management of hypertension and adjunctive therapy in edema associated with congestive heart failure. The label of chlorthalidone tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA211627; the version dated 2022-11-24 in openFDA) calls the medicine a monosulfamyl diuretic that differs chemically from thiazide diuretics, and lists the management of hypertension and the same heart failure edema use. openFDA's records give the established pharmacologic class Thiazide Diuretic for the first label and Thiazide-like Diuretic for the second. MeSH says the thiazide term commonly refers to the benzothiadiazines used as diuretics. It files thiazide diuretics as a concept of the descriptor Sodium Chloride Symporter Inhibitors, agents that act as diuretics.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients described in the indications sections of the two labels: patients with hypertension, and patients with edema associated with congestive heart failure (among other causes the labels list).; Care setting: Prescription medicine, as described in the US labels; Geography: United States (US drug labels); Life stage: Not stated in the passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what two US generic labels say. It is not a finding about how well either medicine works, and no trial result is recorded for it in this atlas. The pharmacologic class names come from openFDA's record of each label. The labels list other uses and a pregnancy statement that were not recorded; contraindications, other warnings, interactions and dosing were not recorded either. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-09
- Sources:
  1. Supports: openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description (Regulator, edition The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22babb1b20-fe82-40ba-8e7a-0c56fe433b4a%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\], INDICATIONS AND USAGE. Retrieved 2026-11-09T13:17:39Z. Source state: Current. Version fingerprint: 84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6.
     How it applies: Hydrochlorothiazide: hypertension and heart failure edema.
  2. Supports: openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description (Regulator, edition The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22babb1b20-fe82-40ba-8e7a-0c56fe433b4a%22&limit=1>
     Locator: results\[0\].openfda.pharm\_class\_epc\[0\]. Retrieved 2026-11-09T13:17:39Z. Source state: Current. Version fingerprint: 84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6.
     How it applies: Established pharmacologic class in openFDA: Thiazide Diuretic.
  3. Background: openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description (Regulator, edition The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22babb1b20-fe82-40ba-8e7a-0c56fe433b4a%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-09T13:17:39Z. Source state: Current. Version fingerprint: 84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6.
     How it applies: Effective date of the label text read, 20260401.
  4. Supports: openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description (Regulator, edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\], INDICATIONS AND USAGE. Retrieved 2026-11-09T13:17:41Z. Source state: Current. Version fingerprint: 5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630.
     How it applies: Chlorthalidone: hypertension and heart failure edema.
  5. Supports: openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description (Regulator, edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1>
     Locator: results\[0\].description\[0\], DESCRIPTION. Retrieved 2026-11-09T13:17:41Z. Source state: Current. Version fingerprint: 5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630.
     How it applies: Chlorthalidone differs chemically from thiazide diuretics.
  6. Supports: openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description (Regulator, edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1>
     Locator: results\[0\].openfda.pharm\_class\_epc\[0\]. Retrieved 2026-11-09T13:17:41Z. Source state: Current. Version fingerprint: 5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630.
     How it applies: Established pharmacologic class in openFDA: Thiazide-like Diuretic.
  7. Background: openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description (Regulator, edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-09T13:17:41Z. Source state: Current. Version fingerprint: 5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630.
     How it applies: Effective date of the label text read, 20221124.
  8. Supports: MeSH scope note for descriptor D049971 (Thiazides) (Dataset, edition MeSH linked-data record of the preferred concept M0471776 of descriptor D049971, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0471776>
     Locator: scopeNote.@value. Retrieved 2026-11-09T13:15:44Z. Source state: Current. Version fingerprint: 8f55829c320bca01d90bd277a7bba2f780bac3669a7cd29cf94af0e707c25da1.
     How it applies: MeSH scope note: what the thiazide term refers to.
  9. Supports: MeSH scope note for descriptor D049993 (Sodium Chloride Symporter Inhibitors) (Dataset, edition MeSH linked-data record of the preferred concept M0471877 of descriptor D049993, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0471877>
     Locator: scopeNote.@value. Retrieved 2026-11-09T14:42:14Z. Source state: Current. Version fingerprint: a43244ed8eef72fe5a73e6d72636c10c164cd63eb440860890bb960d19857b07.
     How it applies: MeSH scope note of the matched descriptor: sodium chloride symporter inhibitors act as diuretics.
  10. Supports: MeSH concept M0006628 (Diuretics, Thiazide) of descriptor D049993 (Sodium Chloride Symporter Inhibitors) (Dataset, edition MeSH linked-data record of concept M0006628, which descriptor D049993 lists among its concepts, fetched 2026-11-09. The descriptor record is its own source, cardio:mesh-d049993.) <https://id.nlm.nih.gov/mesh/M0006628>
     Locator: label.@value. Retrieved 2026-11-09T14:42:23Z. Source state: Current. Version fingerprint: 7119cc10d5b13289e5912295254fa99e0ea0c9a5ef96985ca56463f13bc7d0d4.
     How it applies: MeSH concept of the matched descriptor named Diuretics, Thiazide.

## Connected pages

- Two US labels list managing high blood pressure as an indication: Hypertension (high blood pressure) (`core:hypertension`) [a claim, not a settled fact; see claim `cardio:claim-fda-thiazide-labels-indications` and its context]
- Two US labels list fluid build-up from congestive heart failure as an indication: Heart failure (`cardio:heart-failure`) [a claim, not a settled fact; see claim `cardio:claim-fda-thiazide-labels-indications` and its context]
- Blood pressure lowering medicine, the care strategy: Blood pressure lowering medicine (`cardio:bp-lowering-medicine`)
- Files under this front: Medicines (`cardio:front-medicines`)
- Has subtype: Chlorthalidone (`cardio:chlorthalidone`)
- Has subtype: Hydrochlorothiazide (`cardio:hydrochlorothiazide`)
- Has subtype: Indapamide (`cardio:indapamide`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 5 registry trials

## Provenance

Content hash: 6efd2718f01e794731d09599c48c12e0fb7599e4d5fc85389bcf8fc94874c4bf
Last substantive edit: 2026-11-09
Evidence last checked: 2026-11-09
